Articles

Boston Scientific REPRISE II Clinical Trial Six-month Results Lotus Valve

Further validating its advanced transcatheter aortic valve implantation (TAVI) technology, the Boston Scientific Corp. Lotus Valve System continued to demonstrate impressive performance at six...

CT calcium scoring

There has been growing clinical evidence to show computed tomography (CT) coronary artery calcium scoring shows a close correlation with a person’s long-term risk for heart disease. This data...

As a cardiovascular technology magazine editor, I keep tabs on what technology is in development and often have the opportunity to see the most cutting edge technology up close prior to U.S. Food...

May 27, 2014 — Ekos Corp. announced the U.S. Food and Drug Administration (FDA) has cleared the EkoSonic endovascular system for the ultrasound-facilitated, controlled and selective infusion...

May 23, 2014 — The first drug-eluting balloon to go up for review by the U.S. Food and Drug Administration (FDA) will be discussed at the next Circulatory System Devices Panel of the Medical...

May 23, 2014 — Medtronic announced the results from the first prospective randomized clinical trial to show that Medtronic implantable cardioverter-defibrillators (ICDs) can safely extend...

genetic testing for coronary artery disease

Improved understanding of the molecular mechanism of atherogenesis will help identify disease-related pathways and biomarkers that may also help to predict the future risk in asymptomatic...

ICD Implants Heart Rhythm Society Clinical Study Insurance Male

A study presented at Heart Rhythm 2014, the Heart Rhythm Society’s 35th Annual Scientific Sessions, reports significant gender and health insurance disparities in implantable...

Force, CT, Siemens, dual energy CT

May 21, 2014 — Siemens Healthcare announced that the U.S. Food and Drug Administration (FDA) cleared the Somatom Force computed tomography (CT) system — the next generation in dual source CT....

Journal of Endovascular Therapy Hypertension Renal Denervation Therapy

Patients with hypertension after renal artery stenting who do not respond to drug treatment may have another option.